Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects

A Randomized, Open-label, Oral Dose, Crossover Study to Compare the Safety and Pharmacokinetics Between Co-administration and Fixed Dose Combination of DWC20155 and DWC20156 in Healthy Subjects

The purpose of this study to Compare the safety and pharmacokinetics between co-administration and fixed dose combination of DWC20155 and DWC20156 in healthy subjects

Inclusion Criteria:

• BMI ≥ 18.5 and ≤ 27.0 kg/m2.
• No clinically significant findings
• Age 19-55 years at screening

Exclusion Criteria:

• Who has allergy to investigational product